Karolinska Institutet (KI) (Stockholm, Sweden) founded in 1810, is Sweden’s only university especially focusing on biomedical sciences. In addition, KI annually awards the Nobel Prize in Physiology or Medicine. KI ranks as one of the world’s leading medical universities, thanks in part to the quality of its research activities, which today account for 40 per cent of all medical research in Sweden. KI has about 4 700 employees (full-time equivalents), nearly two-thirds of whom are female. About 80 per cent of KI’s income is devoted to research, distributed among around 600 research groups covering all medical fields. The team at KI has experience with large HPV vaccination trials, epidemiological study designs and assay validation methodologies. The team will lead workpackage 6 and contribute to the development of screening strategies in workpackage 5.
Prof. J. Dillner
Prof. Joakim Dillner, MD, is professor in infectious disease epidemiology at the Department of Laboratory Medicine, Karolinska Institutet and Director of Research & Development at the Karolinska University Laboratory, Karolinska University Hospital. Prof Dillner is a prominent authority in the fields of cancer screening, infections and eScience. He specializes in large-scale molecular testing, including next generation sequencing (NGS) for viral metagenomics. His research group is experienced in large-scale linkages data (for example, comparing health data registries and biospecimen registries for basic science NGS-based projects as well as for translational projects investigating the effect of HPV-based cervical screening and HPV-vaccination). He also works on dynamic transmission models of HPV for design of optimal intervention strategies in different settings. In 2018 he led the founding of a core facility in eHealth at the Karolinska Institutet. Prof. Dillner has published >450 Web of Science-indexed publications in the areas of cancer screening, vaccination, tumor virology, epidemiology and research infrastructures.
Photo credit: Ulf Sirborn
Dr. M. Elfström
Dr. Miriam Elfström, PhD is a post-doc at the Karolinska Institutet and chief development officer of cancer prevention at the Regional Cancer Center in Stockholm which is responsible for the coordination of cancer screening programs in the region. She has worked on cervical screening for the past 8 years and established a track record of evaluating screening methods and prioritizing approaches to strengthening screening programs. She was involved in starting the RHS of primary HPV-based screening in Stockholm and in coordinating a pilot randomized implementation of HPV self-sampling targeting long-term non-attenders.
Photo credit: Gunilla Sonnebring
R. Merino Martinez, MSc
Roxana Merino Martinez, MSc is a system developer who has been involved in several national and EU projects related to informatics infrastructures for biomedical research and biobanking (for instance BioMedBridges, BiobankCloud, RD-Connect, B3Africa). She is highly experienced in high-throughput data and bioinformatics, biobank data management, data harmonization and integration, project management from conception to execution and sustainability.